Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars

October 16, 2023 updated by: Anna Carolina Ratto Tempestini Horliana, University of Nove de Julho

Evaluation of the Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars: a Double-blind Randomized Controlled Study

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars.The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen)These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05.

Study Overview

Detailed Description

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. To control these events, the prophylactic use of anti-inflammatory steroids has been widely recommended by some authors. However, there is no strong evidence on the real benefits of its use as opposed to its possible side effects. Photobiomodulation has proven to be a good alternative when applied in the postoperative period to control pain, edema and lockjaw. On the contrary, its application prior to a procedure of this type has not been sufficiently evaluated. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars. Healthy individuals (ASA I), who have an indication for extraction and are included in the study, will be randomly divided into two groups: Control Group: with the administration of prophylactic Corticosteroid (Dexamethasone 8 mg/ 1h before surgery), and the simulated application of Photobiomodulation, under the same protocol as the Study Group and Study Group: to which Photobiomodulation will be applied by means of intraoral Low Intensity Laser with wavelengths of 660nm and 808nm applied at 4 anatomical points (power of 0.1W, radiant exposure of 1,061 J/cm2 and energy of 3J per point and an application time of 30 seconds, totaling 12J of energy). Besides, the extraoral application will be carried out with a cluster device of combined LEDs with a total exposure area of 20cm2, which will be composed of 5 LEDs with a wavelength of 630nm (power of 0.25W per LED, a radiant exposure of 3 J /cm2 and energy of 12 J per LED spot, with an exposure time of 48 seconds) and 4 LEDs with a wavelength of 850 nm (power of 0.3W per LED, a radiant exposure of 2.4 J/cm2 and an energy of 12J per LED point, and an exposure time of 40 seconds). The Study Group will be administered a placebo tablet simulating Dexamethasone, also 1 h before the surgical procedure. The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen) after the first 3 postoperative days, where Ketorolac 10 mg will be administered orally, in a regulated manner. These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05.

Keywords: photobiomodulation, corticosteroids, extraction, edema, pain, lockjaw, quality of life, randomized controlled trial.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients who present retained lower third molars, according to the degree of surgical difficulty of the procedure and the anatomical position.The selected molars will be those classified according to classes II and III and/or B or C of Pell and Gregory Classification; in vertical or mesio-angular position, according to the Winter Classification or Class II with need for ostectomy or III, with need for ostectomy and odontosection of the Prant Scale, modified by Amarillas-Escobar et al.
  • That have an indication for the extraction of the lower third molars (due to recurrent infections, bad anatomical position, orthodontic indication) or a professional indication presented in writing and that are healthy (ASA I, with a negative medical history).
  • Male or female gender.
  • Age between 18 and 50 years.
  • Good oral hygiene.
  • That they agree to participate in the study, after reading and signing the Informed Consent for participation in clinical research.

Exclusion Criteria:

  • Carriers of local alterations that contraindicate surgical intervention or complicate the postoperative period (example: acute phase pericoronitis in the last 30 days, ankylosis of the temporomandibular joint).
  • Smokers,
  • Presenting absence of upper and lower central incisors,
  • With a medical history of photosensitivity
  • During pregnancy or lactation,
  • That they were using anti-inflammatories or analgesics,
  • Allergic to any of the drugs used in the research (amoxicillin, ketorolac, acetaminophen, dexamethasone, chlorhexidine 2%, local anesthetics, sodium bisulfite, etc.)
  • That during surgery they present any type of complication (bleeding, transoperative difficulties, etc.), because these cases are not included within the expected pattern behavior for this type of surgery (these cases will be reported),
  • Surgical time greater than 90 minutes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Experimental group (n=30 surgeries) - the participants will receive the FBM, 1 hour before the surgical procedure, plus a placebo tablet, with the same physical and organoleptic characteristics, composed of corn starch, without harmful effects on health and simulating Dexamethasone (Celsius Laboratory, Montevideo, Uruguay).).
Intra-oral irradiations wll be performed with a low intensity Laser device at 4 anatomical points, with a wavelength of 660 nm. The extraoral FBM will be applied with 1 cluster (20cm2) with a wavelength of 630nm. Subsequently, the same region will be irradiated with the same cluster, using the 4 LEDs with a wavelength of 850 nm 1 hour before performing the surgery.
Participants will receive 1 hour before the surgery a placebo tablet, with the same physical and organoleptic characteristics, composed of corn starch, without harmful effects on health and simulating Dexamethasone (Celsius Laboratory, Montevideo, Uruguay).).
Active Comparator: Control Group
Control group (n=30 surgeries) - patients will receive conventional treatment with Dexamethasone 8 mg (Corodex, Laboratorio Celsius, Montevideo, Uruguay) PO 1 hour before surgery (Almeida et al 2019), plus simulation of FBM application. The Laser device will be disconnected and will be applied to the same points as in the experimental group, in the immediate pre-operative period (Baseline).
The irradiation simulations will be practiced in the same anatomical points described in the experimental group. This protocol will be carried out 1 hour before the surgical procedure (Baseline). The Laser device will be disconnected and its beep sound will be recorded and run on simulating the irradiation.
The patients will receive Dexamethasone 8 mg (Corodex, Laboratorio Celsius, Montevideo, Uruguay) PO 1 hour before surgery (Almeida et al 2019)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Edema baseline
Time Frame: Edema wil be evaluated immediatly before the surgery (baseline)
To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points
Edema wil be evaluated immediatly before the surgery (baseline)
Postoperative Edema - 48 hours postoperative
Time Frame: Edema wil be evaluated at 2 postoperative days.
To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points.
Edema wil be evaluated at 2 postoperative days.
Postoperative Edema - 7day postoperative
Time Frame: Edema wil be evaluated at 7 postoperative days.
To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points.
Edema wil be evaluated at 7 postoperative days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain baseline
Time Frame: In this study, the VAS will be used immediately before surgery (Baseline)

Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).

A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator

In this study, the VAS will be used immediately before surgery (Baseline)
Postoperative Pain - 48 hours
Time Frame: In this study, the VAS will be used at 2 postoperative days

Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).

A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator

In this study, the VAS will be used at 2 postoperative days
Postoperative Pain - 7 days
Time Frame: In this study, the VAS will be used 7 days before surgery

Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).

A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator

In this study, the VAS will be used 7 days before surgery
Postoperative use of analgesics - baseline
Time Frame: The amount of analgesics will be recorded in the baseline.
Amount of analgesics necessarily ingested, as a rescue: The amount of analgesic (Acetaminophen), a drug with a purely analgesic effect (Józwiak-Bebenista 2014) ingested by the patient (500 mg every 6 hours if the pain continues), will be recorded. At the beginning of the investigation, each patient will be given a form to record daily consumption, after the 3rd. post-operative day, and must be kept until the end of its use, at surgical discharge. At the end of the study, the amount of Acetaminophen tablets used will be evaluated as a secondary variable. The adherence of the participants to the study will be monitored through this means, asking the patients to present the form to verify its use.
The amount of analgesics will be recorded in the baseline.
Postoperative use of analgesics - 7th days
Time Frame: The amount of analgesics will be recorded after the third postoperative day until the 7th. post-operative day.
Amount of analgesics necessarily ingested, as a rescue: The amount of analgesic (Acetaminophen), a drug with a purely analgesic effect (Józwiak-Bebenista 2014) ingested by the patient (500 mg every 6 hours if the pain continues), will be recorded. At the beginning of the investigation, each patient will be given a form to record daily consumption, after the 3rd. post-operative day, and must be kept until the end of its use, at surgical discharge. At the end of the study, the amount of Acetaminophen tablets used will be evaluated as a secondary variable. The adherence of the participants to the study will be monitored through this means, asking the patients to present the form to verify its use.
The amount of analgesics will be recorded after the third postoperative day until the 7th. post-operative day.
Postoperative Trismus - baseline
Time Frame: In the present study, the previously calibrated evaluators will measure the mouth opening in each patient before the surgeries (baseline)
Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroğlu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroğlu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013).
In the present study, the previously calibrated evaluators will measure the mouth opening in each patient before the surgeries (baseline)
Postoperative Trismus 48 hours
Time Frame: In the present study, the previously calibrated evaluators will measure the mouth opening in each patient at 2 postoperative days.
Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroğlu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroğlu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013).
In the present study, the previously calibrated evaluators will measure the mouth opening in each patient at 2 postoperative days.
Postoperative Trismus - 7 days
Time Frame: In the present study, the previously calibrated evaluators will measure the mouth opening in each patient after 7 postoperative days.
Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroğlu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroğlu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013).
In the present study, the previously calibrated evaluators will measure the mouth opening in each patient after 7 postoperative days.
Postoperative Local temperature baseline
Time Frame: baseline
Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made.
baseline
Postoperative Local temperature 48 hours
Time Frame: Thermographic photographs wil be taken 2 days after surgery.
Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made.
Thermographic photographs wil be taken 2 days after surgery.
Postoperative Local temperature - 7 days
Time Frame: Thermographic photographs wil be taken 7 days after surgery.
Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made.
Thermographic photographs wil be taken 7 days after surgery.
Postoperative Quality of life - baseline
Time Frame: Quality of life will be evaluated in the baseline

Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.

  1. Are you maintaining your social activities normally?
  2. Are you working and/or studying normally?
  3. Are you maintaining a normal diet?
  4. Do you have difficulty swallowing because of the surgery?
  5. Do you have difficulty perceiving the taste of food?
  6. Can you chew on the operated side?
  7. Do you have difficulty sleeping because of the surgery?
  8. Do you have difficulty speaking because of the surgery?
  9. Has your physical appearance changed because of the surgery?
  10. Are you angry about the surgery?
Quality of life will be evaluated in the baseline
Postoperative Quality of life - 48 hours
Time Frame: Quality of life will be evaluated two days after surgery,

Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.

  1. Are you maintaining your social activities normally?
  2. Are you working and/or studying normally?
  3. Are you maintaining a normal diet?
  4. Do you have difficulty swallowing because of the surgery?
  5. Do you have difficulty perceiving the taste of food?
  6. Can you chew on the operated side?
  7. Do you have difficulty sleeping because of the surgery?
  8. Do you have difficulty speaking because of the surgery?
  9. Has your physical appearance changed because of the surgery?
  10. Are you angry about the surgery?
Quality of life will be evaluated two days after surgery,
Postoperative Quality of life - 7 days
Time Frame: Quality of life will be evaluated seven days after surgery,

Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.

  1. Are you maintaining your social activities normally?
  2. Are you working and/or studying normally?
  3. Are you maintaining a normal diet?
  4. Do you have difficulty swallowing because of the surgery?
  5. Do you have difficulty perceiving the taste of food?
  6. Can you chew on the operated side?
  7. Do you have difficulty sleeping because of the surgery?
  8. Do you have difficulty speaking because of the surgery?
  9. Has your physical appearance changed because of the surgery?
  10. Are you angry about the surgery?
Quality of life will be evaluated seven days after surgery,
Postoperative Dysphagia baseline
Time Frame: Dysphagia will be evaluated at baseline

Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:

(0)= total absence of dysphagia.

  1. = dysphagia to solid foods.
  2. = dysphagia to any food, liquid or solid.
Dysphagia will be evaluated at baseline
Postoperative Dysphagia 48 hours
Time Frame: Dysphagia will be evaluated at 2 days post-surgery

Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:

(0)= total absence of dysphagia.

  1. = dysphagia to solid foods.
  2. = dysphagia to any food, liquid or solid.
Dysphagia will be evaluated at 2 days post-surgery
Postoperative Dysphagia - 7 days
Time Frame: Dysphagia will be evaluated 7 days post-surgery

Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:

(0)= total absence of dysphagia.

  1. = dysphagia to solid foods.
  2. = dysphagia to any food, liquid or solid.
Dysphagia will be evaluated 7 days post-surgery
Postoperative Hematoma/ecchymosis - baseline
Time Frame: Hematoma/ecchymosis will be evaluated at baseline

The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:

  1. non-existent;
  2. the largest diameter is less than 4 cm;
  3. the largest diameter is between 4 and 10 cm;
  4. the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated at baseline
Postoperative Hematoma/ecchymosis
Time Frame: Hematoma/ecchymosis will be evaluated 2 days after surgery,

The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:

  1. non-existent;
  2. the largest diameter is less than 4 cm;
  3. the largest diameter is between 4 and 10 cm;
  4. the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated 2 days after surgery,
Postoperative Hematoma/ecchymosis - 7 days
Time Frame: Hematoma/ecchymosis will be evaluated 7 days after surgery,

The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:

  1. non-existent;
  2. the largest diameter is less than 4 cm;
  3. the largest diameter is between 4 and 10 cm;
  4. the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated 7 days after surgery,

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2023

Primary Completion (Estimated)

May 31, 2024

Study Completion (Estimated)

July 8, 2024

Study Registration Dates

First Submitted

June 18, 2023

First Submitted That Met QC Criteria

June 28, 2023

First Posted (Actual)

June 29, 2023

Study Record Updates

Last Update Posted (Actual)

October 18, 2023

Last Update Submitted That Met QC Criteria

October 16, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Molar, Third

Clinical Trials on Photobiomodulation

3
Subscribe